PATENT CLAIM ANALYSIS

Application Number: 15861152
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["544", "315000"]

Abstract:
Described are deuterium-substituted tetrahydrocarbazole compounds of Formulae I, II, or III which are inhibitors of sirtuin 1 (SIRT1). Also described are pharmaceutical compositions comprising the deuterium-substituted tetrahydrocarbazole compounds, and methods of use thereof.

Claim (Index 7):
The method of  claim 6 , wherein the autoimmune disease is multiple sclerosis.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.33333
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14718993', '12616242', '15071797', '14297249', '14107953']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7512163956772416
- 35 USC 102 Novelty (BERT): 0.4967648588302406
- Combined Prediction Score: 0.7257712419925416
- Mean Citation Score: 169.692396
- Max Citation Score: 175.61078
- Similarity Product: 104.6537697695482

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test